{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T11:27:55Z","timestamp":1794050875487,"version":"4.8.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T00:00:00Z","timestamp":1725235200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP24he2202020"],"award-info":[{"award-number":["JP24he2202020"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030953","name":"Tokyo Metropolitan Institute for Geriatrics and Gerontology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030953","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP23K14789"],"award-info":[{"award-number":["JP23K14789"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","prd-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.parkreldis.2024.107129","type":"journal-article","created":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T21:54:18Z","timestamp":1725227658000},"page":"107129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Associations of cerebrospinal fluid monoamine metabolites with striatal dopamine transporter binding and 123I-meta-iodobenzylguanidine cardiac scintigraphy in Parkinson's disease: Multivariate analyses"],"prefix":"10.1016","volume":"128","author":[{"given":"Ryosuke","family":"Shimasaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8281-0634","authenticated-orcid":false,"given":"Masanori","family":"Kurihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3497-4714","authenticated-orcid":false,"given":"Keiko","family":"Hatano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1693-9915","authenticated-orcid":false,"given":"Ryoji","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichiro","family":"Taira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoko","family":"Ihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8015-2028","authenticated-orcid":false,"given":"Mana","family":"Higashihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Nishina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9496-2590","authenticated-orcid":false,"given":"Masashi","family":"Kameyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7308-5314","authenticated-orcid":false,"given":"Atsushi","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.parkreldis.2024.107129_bib1","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/mds.25945","article-title":"The prevalence of Parkinson's disease: a systematic review and meta-analysis","volume":"29","author":"Pringsheim","year":"2014","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.parkreldis.2024.107129_bib2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1001\/jamaneurol.2017.3299","article-title":"The Parkinson pandemic-A call to action","volume":"75","author":"Dorsey","year":"2018","journal-title":"JAMA Neurol."},{"issue":"6645","key":"10.1016\/j.parkreldis.2024.107129_bib3","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"issue":"Pt 8","key":"10.1016\/j.parkreldis.2024.107129_bib4","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1093\/brain\/awt192","article-title":"Disease duration and the integrity of the nigrostriatal system in Parkinson's disease","volume":"136","author":"Kordower","year":"2013","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.parkreldis.2024.107129_bib5","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/0006-8993(90)90733-R","article-title":"Loss of brainstem serotonin- and substance P-containing neurons in Parkinson's disease","volume":"510","author":"Halliday","year":"1990","journal-title":"Brain Res."},{"issue":"4","key":"10.1016\/j.parkreldis.2024.107129_bib6","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/ana.410270405","article-title":"Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's disease","volume":"27","author":"Halliday","year":"1990","journal-title":"Ann. Neurol."},{"issue":"Pt 1","key":"10.1016\/j.parkreldis.2024.107129_bib7","first-page":"120","article-title":"Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease","volume":"131","author":"Kish","year":"2008","journal-title":"Brain"},{"issue":"10","key":"10.1016\/j.parkreldis.2024.107129_bib8","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/acn3.246","article-title":"Dopaminergic, serotonergic, and noradrenergic deficits in Parkinson disease","volume":"2","author":"Buddhala","year":"2015","journal-title":"Ann Clin. Transl. Neurol."},{"issue":"6","key":"10.1016\/j.parkreldis.2024.107129_bib9","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/00005072-199111000-00006","article-title":"The neuropathologic basis of different clinical subgroups of Parkinson's disease","volume":"50","author":"Paulus","year":"1991","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"Pt 10","key":"10.1016\/j.parkreldis.2024.107129_bib10","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1093\/brain\/awv215","article-title":"Clinical correlates of raphe serotonergic dysfunction in early Parkinson's disease","volume":"138","author":"Qamhawi","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2024.107129_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2023.114367","article-title":"Serotonin in synucleinopathies","volume":"445","author":"Hsam","year":"2023","journal-title":"Behav. Brain Res."},{"issue":"12","key":"10.1016\/j.parkreldis.2024.107129_bib12","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1136\/jnnp.40.12.1136","article-title":"CSF studies on the relationship between dopamine and 5-hydroxytryptamine in Parkinsonism and other movement disorders","volume":"40","author":"Davidson","year":"1977","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.parkreldis.2024.107129_bib13","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/BF02257622","article-title":"Neurochemical markers in the cerebrospinal fluid of patients with Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis and normal controls","volume":"4","author":"Hartikainen","year":"1992","journal-title":"J. Neural. Transm. Park Dis. Dement. Sect."},{"issue":"8","key":"10.1016\/j.parkreldis.2024.107129_bib14","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1002\/mds.28608","article-title":"Longitudinal analysis of multiple neurotransmitter metabolites in cerebrospinal fluid in early Parkinson's disease","volume":"36","author":"Kremer","year":"2021","journal-title":"Mov. Disord."},{"issue":"1\u20132","key":"10.1016\/j.parkreldis.2024.107129_bib15","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000520302","article-title":"Cerebrospinal fluid levels of 5-hydroxyindoleacetic acid in Parkinson's disease and atypical parkinsonian syndromes","volume":"21","author":"Kaiserova","year":"2021","journal-title":"Neurodegener. Dis."},{"issue":"4","key":"10.1016\/j.parkreldis.2024.107129_bib16","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00702-023-02611-y","article-title":"Correlations between cerebrospinal fluid homovanillic acid and dopamine transporter SPECT in degenerative parkinsonian syndromes","volume":"130","author":"Goto","year":"2023","journal-title":"J. Neural. Transm."},{"issue":"1","key":"10.1016\/j.parkreldis.2024.107129_bib17","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1600-0404.2009.01255.x","article-title":"Cerebrospinal fluid metabolite and nigrostriatal dopaminergic function in Parkinson's disease","volume":"122","author":"Ishibashi","year":"2010","journal-title":"Acta Neurol. Scand."},{"issue":"4","key":"10.1016\/j.parkreldis.2024.107129_bib18","first-page":"349","article-title":"Radiolabeled adrenergi neuron-blocking agents: adrenomedullary imaging with [131I]iodobenzylguanidine","volume":"21","author":"Wieland","year":"1980","journal-title":"J. Nucl. Med."},{"issue":"2","key":"10.1016\/j.parkreldis.2024.107129_bib19","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00006231-199802000-00007","article-title":"Decreased myocardial accumulation of 123I-meta-iodobenzyl guanidine in Parkinson's disease","volume":"19","author":"Yoshita","year":"1998","journal-title":"Nucl. Med. Commun."},{"issue":"1","key":"10.1016\/j.parkreldis.2024.107129_bib20","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0022-510X(97)00278-5","article-title":"Differentiation of idiopathic Parkinson's disease from striatonigral degeneration and progressive supranuclear palsy using iodine-123 meta-iodobenzylguanidine myocardial scintigraphy","volume":"155","author":"Yoshita","year":"1998","journal-title":"J. Neurol. Sci."},{"issue":"5","key":"10.1016\/j.parkreldis.2024.107129_bib21","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1212\/WNL.53.5.1020","article-title":"Cardiac uptake of [123I]MIBG separates Parkinson's disease from multiple system atrophy","volume":"53","author":"Braune","year":"1999","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.parkreldis.2024.107129_bib22","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/jnnp.67.2.189","article-title":"(123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease","volume":"67","author":"Orimo","year":"1999","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"5","key":"10.1016\/j.parkreldis.2024.107129_bib23","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.parkreldis.2012.01.009","article-title":"123I-MIBG myocardial scintigraphy for differentiating Parkinson's disease from other neurodegenerative parkinsonism: a systematic review and meta-analysis","volume":"18","author":"Orimo","year":"2012","journal-title":"Parkinsonism Relat. Disorders"},{"issue":"1","key":"10.1016\/j.parkreldis.2024.107129_bib24","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s10286-011-0135-5","article-title":"MIBG scintigraphy in differential diagnosis of Parkinsonism: a meta-analysis","volume":"22","author":"Treglia","year":"2012","journal-title":"Clin. Auton. Res."},{"issue":"16","key":"10.1016\/j.parkreldis.2024.107129_bib25","doi-asserted-by":"crossref","first-page":"e1648","DOI":"10.1212\/WNL.0000000000200110","article-title":"Autopsy Validation of the diagnostic accuracy of (123)I-metaiodobenzylguanidine myocardial scintigraphy for Lewy body disease","volume":"98","author":"Matsubara","year":"2022","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.parkreldis.2024.107129_bib26","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson's disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"issue":"9","key":"10.1016\/j.parkreldis.2024.107129_bib27","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1136\/jnnp-2015-310327","article-title":"Chronological changes of 123I-MIBG myocardial scintigraphy and clinical features of Parkinson's disease","volume":"86","author":"Tsujikawa","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"4","key":"10.1016\/j.parkreldis.2024.107129_bib28","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/RLU.0000000000002424","article-title":"Initial versus follow-up sequential myocardial 123I-MIBG scintigraphy to discriminate Parkinson disease from atypical parkinsonian syndromes","volume":"44","author":"Ryu","year":"2019","journal-title":"Clin. Nucl. Med."},{"issue":"s2","key":"10.1016\/j.parkreldis.2024.107129_bib29","doi-asserted-by":"crossref","first-page":"S281","DOI":"10.3233\/JPD-191721","article-title":"Brain-first versus gut-first Parkinson's disease: a hypothesis","volume":"9","author":"Borghammer","year":"2019","journal-title":"J. Parkinsons Dis."},{"issue":"10","key":"10.1016\/j.parkreldis.2024.107129_bib30","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1093\/brain\/awaa238","article-title":"Brain-first versus body-first Parkinson's disease: a multimodal imaging case-control study","volume":"143","author":"Horsager","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2024.107129_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2021.105557","article-title":"Neuropathological evidence of body-first vs. brain-first Lewy body disease","volume":"161","author":"Borghammer","year":"2021","journal-title":"Neurobiol. Dis."},{"issue":"2","key":"10.1016\/j.parkreldis.2024.107129_bib32","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3233\/JPD-202481","article-title":"The alpha-synuclein origin and connectome model (SOC model) of Parkinson's disease: explaining motor asymmetry, non-motor phenotypes, and cognitive decline","volume":"11","author":"Borghammer","year":"2021","journal-title":"J. Parkinsons Dis."},{"issue":"1","key":"10.1016\/j.parkreldis.2024.107129_bib33","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41531-022-00436-2","article-title":"A postmortem study suggests a revision of the dual-hit hypothesis of Parkinson's disease","volume":"8","author":"Borghammer","year":"2022","journal-title":"NPJ Parkinsons Dis."},{"issue":"8","key":"10.1016\/j.parkreldis.2024.107129_bib34","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.3233\/JPD-223511","article-title":"Body-first subtype of Parkinson's disease with probable REM-sleep behavior disorder is associated with non-motor dominant phenotype","volume":"12","author":"Pavelka","year":"2022","journal-title":"J. Parkinsons Dis."},{"issue":"6","key":"10.1016\/j.parkreldis.2024.107129_bib35","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00702-023-02633-6","article-title":"The brain-first vs. body-first model of Parkinson's disease with comparison to alternative models","volume":"130","author":"Borghammer","year":"2023","journal-title":"J. Neural. Transm."},{"issue":"10","key":"10.1016\/j.parkreldis.2024.107129_bib36","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1007\/s00702-018-1917-x","article-title":"Cerebrospinal fluid 5-HIAA concentrations correlate with cardiac uptake of (123)I-MIBG during myocardial scintigraphy in drug naive Parkinson's disease","volume":"125","author":"Murakami","year":"2018","journal-title":"J. Neural. Transm."},{"issue":"1","key":"10.1016\/j.parkreldis.2024.107129_bib37","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.parkreldis.2024.107129_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171524","article-title":"Homovanillic acid and 5-hydroxyindole acetic acid as biomarkers for dementia with Lewy bodies and coincident Alzheimer's disease: an autopsy-confirmed study","volume":"12","author":"Morimoto","year":"2017","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.parkreldis.2024.107129_bib39","doi-asserted-by":"crossref","first-page":"e1009","DOI":"10.1212\/WNL.0000000000201647","article-title":"CSF P-Tau 181 and other biomarkers in patients with neuronal intranuclear inclusion disease","volume":"100","author":"Kurihara","year":"2023","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.parkreldis.2024.107129_bib40","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40658-017-0175-6","article-title":"[(123)I]FP-CIT ENC-DAT normal database: the impact of the reconstruction and quantification methods","volume":"4","author":"Tossici-Bolt","year":"2017","journal-title":"EJNMMI Phys"},{"issue":"8","key":"10.1016\/j.parkreldis.2024.107129_bib41","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1007\/s00259-018-3976-5","article-title":"Japanese multicenter database of healthy controls for [(123)I]FP-CIT SPECT","volume":"45","author":"Matsuda","year":"2018","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"issue":"5","key":"10.1016\/j.parkreldis.2024.107129_bib42","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1007\/s12350-014-9916-2","article-title":"Multicenter cross-calibration of I-123 metaiodobenzylguanidine heart-to-mediastinum ratios to overcome camera-collimator variations","volume":"21","author":"Nakajima","year":"2014","journal-title":"J. Nucl. Cardiol."},{"issue":"20","key":"10.1016\/j.parkreldis.2024.107129_bib43","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.2169\/internalmedicine.0876-18","article-title":"HIV dementia with a decreased cardiac (123)I-metaiodobenzylguanidine uptake masquerading as dementia with Lewy bodies","volume":"57","author":"Kurihara","year":"2018","journal-title":"Intern Med"},{"issue":"2","key":"10.1016\/j.parkreldis.2024.107129_bib44","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"issue":"4","key":"10.1016\/j.parkreldis.2024.107129_bib45","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jchemneu.2003.10.002","article-title":"The human raphe nuclei and the serotonergic system","volume":"26","author":"Hornung","year":"2003","journal-title":"J. Chem. Neuroanat."},{"issue":"4","key":"10.1016\/j.parkreldis.2024.107129_bib46","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/mds.29317","article-title":"Clinical diagnostic accuracy of Parkinson's disease: where do we stand?","volume":"38","author":"Virameteekul","year":"2023","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.parkreldis.2024.107129_bib47","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40035-023-00374-w","article-title":"Large-scale proximity extension assay reveals CSF midkine and DOPA decarboxylase as supportive diagnostic biomarkers for Parkinson's disease","volume":"12","author":"Paslawski","year":"2023","journal-title":"Transl. Neurodegener."},{"issue":"10","key":"10.1016\/j.parkreldis.2024.107129_bib48","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1038\/s43587-023-00478-y","article-title":"DOPA decarboxylase is an emerging biomarker for Parkinsonian disorders including preclinical Lewy body disease","volume":"3","author":"Pereira","year":"2023","journal-title":"Nat. Aging."},{"key":"10.1016\/j.parkreldis.2024.107129_bib49","doi-asserted-by":"crossref","DOI":"10.1002\/mds.29835","article-title":"Increased CSF DOPA decarboxylase correlates with lower DaT-SPECT binding: analyses in biopark and PPMI cohorts","author":"Khosousi","year":"2024","journal-title":"Mov. Disord."}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802024011416?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802024011416?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T21:11:15Z","timestamp":1730495475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802024011416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":49,"alternative-id":["S1353802024011416"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2024.107129","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Associations of cerebrospinal fluid monoamine metabolites with striatal dopamine transporter binding and 123I-meta-iodobenzylguanidine cardiac scintigraphy in Parkinson's disease: Multivariate analyses","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2024.107129","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107129"}}